Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 1 bulk ingredient, 1 drug for further processing. By marketing category: BULK INGREDIENT 1, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| injection, solution | 1 |
| liquid | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| hospira zagreb d.o.o. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Filgrastim | liquid | 71861-0001BULK INGREDIENT |
| - | anakinra | injection, solution | 71861-0234DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing filgrastim
- Amgen, Inc9 sites · 105 NDC
- Amneal Ireland Limited1 site · 513 NDC
Enquiry
Common questions
- Is Hospira Zagreb d.o.o. FDA approved?
- Hospira Zagreb d.o.o. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Hospira Zagreb d.o.o. make?
- 2 products are listed under Hospira Zagreb d.o.o. in the openFDA NDC Directory, most often as injection, solution; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.